Evaluation of Regenerative Medicine Outcomes With Umbilical Allograft for Musculoskeletal Conditions
R3 Stem Cell
Summary
The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.
Description
Medical providers are often faced with patients whose source of pain may be the result of an inflammatory response caused by trauma or disease. By managing the patient's inflammation, the clinician may see improved response to traditional pain management therapy and existing protocols. Also, degenerative arthritis of spinal and extremity joints may lead to significant low back, knee, hip, shoulder pain etc, as the ratio of cartilage degradation to cartilage formation increases with age. An amniotic tissue derived product may prove to be an ideal non-steroidal and potentially regenerative ther…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Age 18 and over. 2. Ability to attend follow up visits or at least converse on phone or complete email follow up forms. 4\) Competent to understand the study protocol and provide voluntary informed consent. Exclusion Criteria: 1. Active Infection 2. Pregnancy, Lactating 3. Clotting disorder
Interventions
- OtherUmbilical Allograft
The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.
Location
- Advanced Stem Cell InstituteEncino, California